NIH News Releases

Syndicate content NIH News Release
News releases from the National Institutes of Health (NIH)
Updated: 8 hours 24 min ago

Preterm birth, prolonged labor influenced by progesterone balance

March 11, 2021 - 10:30pm
Novel research in mice sheds light on hormone regulation needed in late pregnancy, opens door for therapy.

Categories: NIH

NIH awards grants to support bacteriophage therapy research

March 11, 2021 - 8:00pm
“Phage” therapies offer potential strategy to combat antibacterial resistance.

Categories: NIH

NIH-led team sets new bar in retinal imaging

March 11, 2021 - 7:30pm
By eliminating extraneous light, the scientists improved resolution by 33%.

Categories: NIH

NIH researchers develop guidelines for reporting polygenic risk scores

March 10, 2021 - 5:00pm
Researchers hope the new approach will be used as a framework for publishing studies on polygenic risk scores. .

Categories: NIH

Study of mosquito protein could lead to treatments against life-threatening viruses

March 10, 2021 - 3:45pm
Protein AEG12 strongly inhibits the family of viruses that cause yellow fever, dengue, West Nile, and Zika.

Categories: NIH

NIH scientists use human cerebral organoid to test drug for deadly brain disease

March 9, 2021 - 10:30pm
NIH, NIAID, scientists, human, cerebral organoid, test, drug, Creutzfeldt-Jakob disease.

Categories: NIH

Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19

March 8, 2021 - 5:00pm
Trial explores the use of the Eliquis® in patients who have been discharged from the hospital following a diagnosis of moderate-to-severe COVID-19.

Categories: NIH

NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies

March 4, 2021 - 6:30pm
ACTIV-3 is a master protocol designed to allow for the study of multiple investigational agents compared to placebo in adults hospitalized with COVID-19.

Categories: NIH

NIH scientists discover how DNA fragments can trigger inflammation in sickle cell disease

March 4, 2021 - 4:00pm
Finding could lead to new ways to reduce complications from painful red blood cell disorder.

Categories: NIH

NIH invests in next iteration of public-private partnership to advance precision medicine research for Alzheimer’s disease

March 2, 2021 - 8:00pm
Effort is part of the Accelerating Medicines Partnership to enable development of effective targeted therapies.

Categories: NIH

NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms

March 2, 2021 - 6:30pm
Study shows the treatment is safe, but provides no significant benefit in this group.

Categories: NIH

Law enforcement seizures of methamphetamine and marijuana rose during pandemic

March 2, 2021 - 6:00pm
Findings suggest that the pandemic may have impacted the availability and demand of some, but not all, illegal drugs.

Categories: NIH

NIH effort seeks to understand MIS-C, range of SARS-CoV-2 effects on children

March 2, 2021 - 3:15pm
Program to investigate why some children are at greater risk for SARS-CoV-2 infection than others.

Categories: NIH

NIH to evaluate COVID-19 at-home testing system

March 1, 2021 - 5:00pm
Newly authorized COVID-19 diagnostic kit is paired with smartphone app.

Categories: NIH

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine

February 28, 2021 - 1:45am
The single-shot vaccine is the third COVID-19 vaccine in the United States to be granted an EUA.

Categories: NIH

Study identifies cardiovascular risk factors that may lead to pregnancy problems for first-time moms

February 26, 2021 - 2:30pm
NIH-supported findings also show cardiovascular risks and pregnancy complications can raise chances of hypertension years after childbirth .

Categories: NIH

New experiences enhance learning by resetting key brain circuit

February 24, 2021 - 5:00pm
NIH-funded study shows how novelty triggers neural mechanisms that facilitate flexible strategy encoding

Categories: NIH

NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection

February 24, 2021 - 5:00pm
Results may explain why reinfection appears to be relatively rare.

Categories: NIH

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial

February 23, 2021 - 8:00pm
Antibodies were well tolerated and generally safe when administered simultaneously to healthy adults.

Categories: NIH

Mouse study shows bacteriophage therapy could fight drug-resistant Klebsiella pneumoniae

February 23, 2021 - 3:00pm
Using viruses instead of antibiotics to tame troublesome drug-resistant bacteria is a promising strategy.

Categories: NIH